Bayer AG is investing €100m ($113m) in its Consumer Health division to “enable sustainable innovation, production and consumption” of major OTC brands like Aspirin, Bepanthen, Claritin and Elevit.
Equating to 2% of the division’s sales, Bayer said the investment will help “drive the sustainable use of the company’s...